Article Text
Prognosis
Review: one tenth of patients with Crohn’s disease have prolonged remission
Statistics from Altmetric.com
Footnotes
-
Source of funding: AstraZeneca LP.
-
For correspondence: Dr E V Loftus, Jr, Mayo Clinic, Rochester, MN, USA. E-mail loftus.edward{at}mayo.edu.